Related Experiment Video
Updated: Jan 30, 2026
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Impact of p85α Alterations in Cancer
Jeremy D S Marshall1,2, Dielle E Whitecross3, Paul Mellor4
1Cancer Research Group, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada. jem826@mail.usask.ca.
Abstract:
The phosphatidylinositol 3-kinase (PI3K) pathway plays a central role in the regulation of cell signaling, proliferation, survival, migration and vesicle trafficking in normal cells and is frequently deregulated in many cancers. The p85α protein is the most characterized regulatory subunit of the class IA PI3Ks, best known for its regulation of the p110-PI3K catalytic subunit. In this review, we will discuss the impact of p85α mutations or alterations in expression levels on the proteins p85α is known to bind and regulate. We will focus on alterations within the N-terminal half of p85α that primarily regulate Rab5 and some members of the Rho-family of GTPases, as well as those that regulate PTEN (phosphatase and tensin homologue deleted on chromosome 10), the enzyme that directly counteracts PI3K signaling. We highlight recent data, mapping the interaction surfaces of the PTEN⁻p85α breakpoint cluster region homology (BH) domain, which sheds new light on key residues in both proteins. As a multifunctional protein that binds and regulates many different proteins, p85α mutations at different sites have different impacts in cancer and would necessarily require distinct treatment strategies to be effective.
Insights
Mutations in the p85α protein, a key regulator of the phosphatidylinositol 3-kinase (PI3K) pathway, impact its interactions and cancer progression. Different p85α mutations necessitate distinct cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- The phosphatidylinositol 3-kinase (PI3K) pathway is crucial for cell functions and often dysregulated in cancers.
- p85α is the primary regulatory subunit of class IA PI3Ks, controlling the p110 catalytic subunit.
Purpose of the Study:
- To review the impact of p85α mutations and expression alterations on its binding partners.
- To focus on N-terminal p85α alterations affecting Rab5, Rho GTPases, and PTEN.
- To highlight new data on PTEN-p85α interactions.
Main Methods:
- Literature review focusing on p85α interactions and cancer relevance.
- Analysis of structural data for PTEN-p85α binding interfaces.
- Discussion of mutation-specific effects on protein regulation.
Main Results:
- Alterations in p85α affect its regulation of Rab5, Rho GTPases, and PTEN.
- Mapping of PTEN-p85α interaction surfaces reveals key residues.
- Different p85α mutation sites have distinct effects on cancer signaling.
Conclusions:
- p85α is a multifunctional protein with mutations having varied impacts on cancer.
- Understanding specific p85α alterations is essential for developing targeted cancer therapies.
Related Concept Videos
01:30Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
01:06Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
01:19Impact of Groups on Groups
01:30Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
01:30Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
01:28Impact of Groups on Individuals